2BB score and signals
Context Therapeutics Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 16 | Very Low |
| Momentum | 43 | Stable |
| Financial strength | 21 | Weak |
| Quality | 40 | Normal |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Philadelphia, Pennsylvania, United States |
| Founded | 2015 |
| Employees | 15 |
| 52-week range | $0.43 – $3.62 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.1109 | — | $0.00 |
| 2026-08-12 | — | -0.0941 | — | $0.00 |
| 2026-05-06 | -0.09 | -0.1197 | $0.00 | $0.00 |
| 2026-03-23 | -0.14 | -0.1082 | $0.00 | $0.00 |
Related companies
